The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Conmed Corp. shares valued at $157,181 were purchased by Peters Stanley W III on Aug 27 ’24. At $72.40 per share, Peters Stanley W III acquired 2,171 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Peters Stanley W III sold 4,000 shares, netting a total of over 287,280 in proceeds. Following the sale of shares at $71.82 each, the insider now holds 63 shares.
Before that, BRONSON DAVID M had added 1,350 shares to its account. In a trade valued at $97,322, the Director bought Conmed Corp. shares for $72.09 each. Upon closing the transaction, the insider’s holdings increased to 1,350 shares, worth approximately $1.02 million.
As published in a research note from Needham on February 01, 2024, Conmed Corp. [CNMD] has been retained to a Buy and the price target has been revised to $129. Analysts at CL King started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of March 27, 2023, KeyBanc Capital Markets has increased its “Sector weight” rating to a “an Overweight” for CNMD. Earlier on March 21, 2023, Wells Fargo initiated its rating. Their recommendation was “an Equal weight” for CNMD stock.
Analyzing CNMD Stock Performance
During the last five days, there has been a drop of approximately -7.14%. Over the course of the year, Conmed Corp. shares have dropped approximately -43.56%. Shares of the company reached a 52-week high of $113.68 on 01/12/24 and a 52-week low of $61.05 on 04/25/24. A 50-day SMA is recorded $70.24, while a 200-day SMA reached $77.59. Nevertheless, trading volume fell to 0.61 million shares from 0.44 million shares the previous day.
Support And Resistance Levels for Conmed Corp. (CNMD)
According to the 24-hour chart, there is a support level at 61.12, which, if violated, would cause prices to drop to 60.44. In the upper region, resistance lies at 62.82. The next price resistance is at 63.83. RSI (Relative Strength Index) is 25.99 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -6.17, which suggests the price will decrease in the coming days. Percent R is at 97.70%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
